150 related articles for article (PubMed ID: 37027168)
61. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.
Haldorsen IS; KrÄkenes J; Krossnes BK; Mella O; Espeland A
AJNR Am J Neuroradiol; 2009 Apr; 30(4):744-51. PubMed ID: 19164442
[TBL] [Abstract][Full Text] [Related]
62. Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival duration.
Huntoon K; Makary MS; Shah VS; Aquino A; Pandya V; Giglio P; Slone HW; Elder JB
Neuroradiol J; 2023 Aug; 36(4):479-485. PubMed ID: 36715098
[TBL] [Abstract][Full Text] [Related]
63. Primary central nervous system lymphoma with systemic metastasis: case report and review.
Brown MT; McClendon RE; Gockerman JP
J Neurooncol; 1995; 23(3):207-21. PubMed ID: 7673983
[TBL] [Abstract][Full Text] [Related]
64. Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature.
Grillo P; DI Giuliano F; Massa R; Mercuri NB; Schirinzi T
Neurol Sci; 2021 Mar; 42(3):905-910. PubMed ID: 33443666
[TBL] [Abstract][Full Text] [Related]
65. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK
Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
[TBL] [Abstract][Full Text] [Related]
66. Primary central nervous system lymphoma in a patient with systemic lupus erythematosus mimicking high-grade glioma: A case report and review of literature.
Su L; Ding M; Chen L; Li C; Lao M
Medicine (Baltimore); 2018 Jun; 97(23):e11072. PubMed ID: 29879076
[TBL] [Abstract][Full Text] [Related]
67. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
[TBL] [Abstract][Full Text] [Related]
68. Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme.
Cerqua R; Balestrini S; Perozzi C; Cameriere V; Renzi S; Lagalla G; Mancini G; Montanari M; Leoni P; Scerrati M; Iacoangeli M; Silvestrini M; Luzzi S; Provinciali L
Neurol Sci; 2016 Jan; 37(1):23-29. PubMed ID: 26233232
[TBL] [Abstract][Full Text] [Related]
69. Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.
Kawai N; Okubo S; Miyake K; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Ann Nucl Med; 2010 Jun; 24(5):335-43. PubMed ID: 20379859
[TBL] [Abstract][Full Text] [Related]
70. Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis.
Zhang Y; Liu Z; Gao C; Bian H; Ma Y; Jing F; Zhao X
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):733-741. PubMed ID: 37453867
[TBL] [Abstract][Full Text] [Related]
71. Treatment of primary central nervous system lymphoma.
Deangelis LM; Hormigo A
Semin Oncol; 2004 Oct; 31(5):684-92. PubMed ID: 15497122
[TBL] [Abstract][Full Text] [Related]
72. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
[TBL] [Abstract][Full Text] [Related]
73. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
[TBL] [Abstract][Full Text] [Related]
74. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
Abdel Razek AAK; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
World Neurosurg; 2019 Mar; 123():e303-e309. PubMed ID: 30502475
[TBL] [Abstract][Full Text] [Related]
75. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
[TBL] [Abstract][Full Text] [Related]
76. Primary central nervous system lymphoma.
Schaff LR; Grommes C
Blood; 2022 Sep; 140(9):971-979. PubMed ID: 34699590
[TBL] [Abstract][Full Text] [Related]
77. Challenges and opportunities in primary CNS lymphoma: A systematic review.
Kerbauy MN; Moraes FY; Lok BH; Ma J; Kerbauy LN; Spratt DE; Santos FP; Perini GF; Berlin A; Chung C; Hamerschlak N; Yahalom J
Radiother Oncol; 2017 Mar; 122(3):352-361. PubMed ID: 28104300
[TBL] [Abstract][Full Text] [Related]
78. Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapy.
Shah JJ; Meredith R; Shen S; Nabors B; Lobuglio A; Yester M; Forero A
Clin Lymphoma Myeloma; 2006 Nov; 7(3):236-8. PubMed ID: 17229341
[TBL] [Abstract][Full Text] [Related]
79. Unusual variants of primary central nervous system lymphoma.
Shenkier TN
Hematol Oncol Clin North Am; 2005 Aug; 19(4):651-64, vi. PubMed ID: 16083828
[TBL] [Abstract][Full Text] [Related]
80. Neuroinflammation Preceding and Accompanying Primary Central Nervous System Lymphoma: Case Study and Literature Review.
Lu JQ; O'Kelly C; Girgis S; Emery D; Power C; Blevins G
World Neurosurg; 2016 Apr; 88():692.e1-692.e8. PubMed ID: 26724610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]